Australian digital health manufacturer Atmo Biosciences has raised AUD 9.6 million and won the support of global pharmaceutical players to meet unmet clinical, consumer and medical device needs. Mr, Malcolm Hebblewhite, the CEO of Atmo Biosciences shares the goals that they are eying after achieving such astounding success.
Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.
Recent Articles
Sponsored
EcoGraf appoints veteran Hatch and Rio Tinto Executive as new COO
- July 06, 2022 03:59 PM AEST
- Akshay
Sponsored
How has Vanadium Resources (ASX:VR8) fared during the second half of FY22
- July 06, 2022 03:51 PM AEST
- Nitish Kumar
Stock Market
ASIA, HACK, ESPO: How have these three ASX ETFs fared YTD?
- July 06, 2022 02:50 PM AEST
- Ashish
_07_06_2022_17_08_57_122554.png "Best degrees for stock trading and investing")
_07_06_2022_17_04_21_331173.png "Will NFTs offer more benefits across sectors in the future? | Expert talks with Andy Crosby")
_07_06_2022_16_57_25_740386.png "Judo Bank exceeds GLA target to AU$6.09B in June ’22")
Be the First to Comment